Target-fueled nuclear reactor for medical isotope production
Abstract
A small, low-enriched, passively safe, low-power nuclear reactor comprises a core of target and fuel pins that can be processed to produce the medical isotope .sup.99Mo and other fission product isotopes. The fuel for the reactor and the targets for the .sup.99Mo production are the same. The fuel can be low enriched uranium oxide, enriched to less than 20% .sup.235U. The reactor power level can be 1 to 2 MW. The reactor is passively safe and maintains negative reactivity coefficients. The total radionuclide inventory in the reactor core is minimized since the fuel/target pins are removed and processed after 7 to 21 days.
- Inventors:
- Issue Date:
- Research Org.:
- Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1366488
- Patent Number(s):
- 9691511
- Application Number:
- 12/845,497
- Assignee:
- Sandia Corporation
- Patent Classifications (CPCs):
-
G - PHYSICS G21 - NUCLEAR PHYSICS G21G - CONVERSION OF CHEMICAL ELEMENTS
- DOE Contract Number:
- AC04-94AL85000
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2010 Jul 28
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS
Citation Formats
Coats, Richard L., and Parma, Edward J. Target-fueled nuclear reactor for medical isotope production. United States: N. p., 2017.
Web.
Coats, Richard L., & Parma, Edward J. Target-fueled nuclear reactor for medical isotope production. United States.
Coats, Richard L., and Parma, Edward J. Tue .
"Target-fueled nuclear reactor for medical isotope production". United States. https://www.osti.gov/servlets/purl/1366488.
@article{osti_1366488,
title = {Target-fueled nuclear reactor for medical isotope production},
author = {Coats, Richard L. and Parma, Edward J.},
abstractNote = {A small, low-enriched, passively safe, low-power nuclear reactor comprises a core of target and fuel pins that can be processed to produce the medical isotope .sup.99Mo and other fission product isotopes. The fuel for the reactor and the targets for the .sup.99Mo production are the same. The fuel can be low enriched uranium oxide, enriched to less than 20% .sup.235U. The reactor power level can be 1 to 2 MW. The reactor is passively safe and maintains negative reactivity coefficients. The total radionuclide inventory in the reactor core is minimized since the fuel/target pins are removed and processed after 7 to 21 days.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2017},
month = {6}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Production of High Purity Fission Product Molybdenum-99
patent, March 1974
- Arino, Hirofumi; Kramer, Henry H.; McGovern, James J.
- US Patent Document 3,799,883
Novel method of producing radioactive iodine
patent, December 1976
- Shikata, Eiji; Amano, Hiroshi
- US Patent Document 3,998,691
Reactor containment facilities
patent, March 1994
- Tominaga, Kenji; Horiuchi, Tetsuo; Niino, Tsuyoshi
- US Patent Document 5,295,169
Medical isotope production reactor
patent, January 1997
- Ball, Russell M.
- US Patent Document 5,596,611
Light water reactor core and fuel assembly
patent, January 2003
- Takeda, Renzo; Aoyama, Motoo; Miwa, Junichi
- US Patent Document 6,512,805
Handoff Methods And Assemblies For Refueling A Nuclear Reactor
patent-application, July 2008
- Ortega, Frank; Broaddus, Mark
- US Patent Application 11/618439; 20080159463